Home/STAAR Surgical/Keith A. Holliday

KA

Keith A. Holliday

SVP, General Counsel & Corporate Secretary

Therapeutic Areas

Ophthalmology Refractive Surgery

STAAR Surgical Pipeline

Drug	Indication	Phase
EVO ICL / EVO+ ICL	Myopia & Myopia with Astigmatism	Commercial
Hyperopic ICL	Hyperopia (Farsightedness)	Commercial (Limited)
Presbyopia-Correcting ICL	Presbyopia	Research & Development

Leadership Team at STAAR Surgical

President and Chief Executive Officer

Patrick F. Williams

Chief Financial Officer

A. John Barnhart

Chief Operating Officer

Dr. Gary M. Wörtz

Chief Medical Officer

View full STAAR Surgical profile